Results 91 to 100 of about 2,083 (199)

Production of fast ion and nuclei bunches of solid densities from nanolayers by ultrarelativistic laser pulses

Physical Review Special Topics. Accelerators and Beams, 2011
A method for generation of quasimonoenergetic, low emittance fast ion/nuclei bunches of solid densities from nanotargets by two counterpropagating laser pulses of ultrarelativistic intensities is proposed, based on the threshold phenomenon of particles ...
H. K. Avetissian, A. K. Avetissian, G. F. Mkrtchian, Kh. V. Sedrakian   +3 more
doaj   +1 more source

scCVD diamond membrane based microdosimeter for hadron therapy [PDF]

, 2018
Hadron therapy is an innovative mode of radiation therapy for cancer treatment which enables tumour cells to be more effectively destroyed than conventional radiation therapy using photons.
SAADA, Samuel, BARBERET, Philippe, ZAHRADNIK, Izabella, TROMSON, Dominique, BERGONZO, Philippe, NATKO, Stukan, POMORSKI, Michal, KADA, Wataru, DE MARZI, Ludovic   +8 more
core  

Hadron therapy : between medical need and economic expediency [PDF]

, 2005
peer reviewedThe time is ripe for a Belgian hadron therapy centre. The medical advantages are well documented. The scientific and technical conditions are present.The political will is expected as well as the necessary funding.
Storme, Guy, Jacquet de Haveskercke, Paul, De Neve, Wilfried, Scalliet, Pierre, Lievens, Yolande, Deneufbourg, Jean-Marie, Vander Steichel, Didier, Van den Bogaert, Walter, Van Houtte, Paul   +8 more
core  

Crystal Channelling for Hadron Therapy Accelerators [PDF]

, 2022
In this study, the effect of crystal channelling in low energy (kinetic energy from 60 to 250MeV) proton beam which is the energy range required for hadron therapy treatments in a medical accelerator is investigated.
Ng, Hoi Lun
core  

Nuclear physics and particle therapy

EPJ Web of Conferences, 2016
The use of charged particles and nuclei in cancer therapy is one of the most successful cases of application of nuclear physics to medicine. The physical advantages in terms of precision and selectivity, combined with the biological properties of densely
Battistoni G.
doaj   +1 more source

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation

Journal of Bone Oncology, 2019
Chondrosarcoma is a malignant tumor that arises from cartilaginous tissue and is radioresistant and chemoresistant to conventional treatments. The preferred treatment consists of surgical resection, which might cause severe disabilities for the patient ...
Mathieu Césaire, Utpal Ghosh, Jean-Baptiste Austry, Etienne Muller, Francesco Paolo Cammarata, Marilyne Guillamin, Massimo Caruso, Laurent Castéra, Giada Petringa, Giuseppe Antonio Pablo Cirrone, François Chevalier   +10 more
doaj   +1 more source

Paving the Road for Modern Particle Therapy – What can we Learn from the experience gained with Fast Neutron Therapy in Munich?

Frontiers in Oncology, 2015
While neutron therapy was a highly topical subject in the 70’s and 80’s, today there are only a few remaining facilities offering fast neutron therapy. Nevertheless, up to today more than 30,000 patients were treated with neutron therapy.
Hanno Martin Specht, Teresa eNeff, Waltraud eReuschel, Franz Michael Wagner, Severin eKampfer, Jan Jakob Wilkens, Jan Jakob Wilkens, Winfried ePetry, Stephanie E Combs, Stephanie E Combs   +9 more
doaj   +1 more source

CVD diamonds used in the ATLAS pixel detector and in hadron therapy [PDF]

, 2016
A 13cm diameter wafer of polycrystalline CVD diamonds.
ATLAS Collaboration
core  

Ion charge separation with new generation of nuclear emulsion films

Open Physics, 2019
In hadron therapy, the accelerated ions, interacting with the body of the patient, cause the fragmentation of both projectile and target nuclei. The fragments interact with the human tissues depositing energy both in the entrance channel and in the ...
Montesi M.C., Lauria A., Alexandrov A., Solestizi L. Alunni, Giovanni Ambrosi, Argirò S., Diaz R. Arteche, Bartosik N., Battistoni G., Belcari N., Bellinzona E., Bianucci S., Biondi S., Bisogni M.G., Bruni G., Camarlinghi N., Carra P., Cerello P., Ciarrocchi E., Clozza A., Colombi S., Guerra A. Del, Simoni M. De, Crescenzo A. Di, Donetti M., Dong Y., Durante M., Embriaco A., Emde M., Faccini R., Ferrero V., Ferroni F., Fiandrini E., Finck C., Fiorina E., Fischetti M., Francesconi M., Franchini M., Galati G., Galli L., Garbini M., Gentile V., Giraudo G., Hetzel R., Iarocci E., Ionica M., Kanxheri K., Kraan A. C., Lante V., Tessa C. La, Torres E. Lopez, Marafini M., Mattei I., Mengarelli A., Mirabelli R., Moggi A., Morone M.C., Morrocchi M., Muraro S., Narici L., Pastore A., Pastrone N., Patera V., Pennazio F., Placidi P., Pullia M., Raffaelli F., Ramello L., Ridolfi R., Rosso V., Rovituso M., Sanelli C., Sarti A., Sartorelli G., Sato O., Savazzi S., Scavarda L., Schiavi A., Schuy C., Scifoni E., Sciubba A., Sécher A., Selvi M., Servoli L., Silvestre G., Sitta M., Spighi R., Spiriti E., Sportelli G., Stahl A., Tioukov V., Tomassini S., Tommasino F., Traini G., Valle S.M., Vanstalle M., Villa M., Weber U., Zoccoli A., Lellis G. De   +99 more
doaj   +1 more source